Clinical trial · Interventional
Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer
Multicenter (Phase II) Study of Oncoplastic Surgical Techniques for Breast Conservation in Breast Cancers
NCT00870415CI-TRIAL-00029176completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Breast-conserving surgery is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This phase II trial is studying different breast-conserving surgery techniques in treating women with breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| quality-of-life assessment | Procedure | — | UNRESOLVED |
| therapeutic conventional surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Surgerie
- interventionNames
- Procedure: quality-of-life assessment
- Procedure: therapeutic conventional surgery
Primary outcomes (1)
- measure
- Percentage of histologically healthy margins maintained during resection
- timeFrame
- From inclusion to end of intervention
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Meets 1 of the following criteria: * Diagnosis of intraductal breast cancer requiring a wide local resection * Diagnosis of infiltrating ductal breast cancer within range * Diagnosis of invasive breast cancer that has not responded well to neoadjuvant treatment * No multicentric tumor * No gigantomastia * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Menopausal status not specified * No patients subject to a measure of legal protection or unable to express consent * No patients deprived of liberty by judicial or administrative decision or hospitalized without patient consent * Not pregnant or nursing PRIOR CONCURRENT THERAPY: * No prior radiotherapy to the diseased breast * No prior adjuvant treatment * No concurrent participation in another clinical research study
References
Publications (0)
Data not yet available
No reference posted for this study.